FDA Drug recall D-0143-2020
Dextroamphetamine Sacharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, Mixed Salts of a single Enti…
- FDA Drug
- Class II
- terminated
- Published 2019-10-23
On 2019-10-23 the FDA classified a Class II recall of Dextroamphetamine Sacharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, Mixed Salts of a single Enti… by Aurobindo Pharma Usa, citing superpotent Drug: Amphetamine Mixed Salts 20mg have been found to be out of specification for weight and thickness.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0143-2020 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2019-09-19 |
| Published | 2019-10-23 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Aurobindo Pharma Usa |
| Distribution | US |
Product
Dextroamphetamine Sacharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, Mixed Salts of a single Entity Amphetamine Product), 20mg, 100-count bottle, RX Only, Distributed by: Aurobindo Pharma USA Inc., Dayton, NJ 08810, NDC 13107-073-01
Reason
Superpotent Drug: Amphetamine Mixed Salts 20mg have been found to be out of specification for weight and thickness.
Identifiers
| ndc | 13107-068-50 |
|---|---|
| ndc | 13107-068-01 |
| ndc | 13107-068-25 |
| ndc | 13107-068-05 |
| ndc | 13107-068-99 |
| ndc | 13107-069-50 |
| ndc | 13107-069-01 |
| ndc | 13107-069-25 |
| ndc | 13107-069-05 |
| ndc | 13107-069-99 |
| ndc | 13107-070-50 |
| ndc | 13107-070-01 |
| ndc | 13107-070-25 |
| ndc | 13107-070-05 |
| ndc | 13107-070-99 |
| ndc | 13107-071-50 |
| ndc | 13107-071-01 |
| ndc | 13107-071-25 |
| ndc | 13107-071-05 |
| ndc | 13107-071-99 |
| ndc | 13107-072-50 |
| ndc | 13107-072-01 |
| ndc | 13107-072-25 |
| ndc | 13107-072-05 |
| ndc | 13107-072-99 |
| ndc | 13107-073-50 |
| ndc | 13107-073-01 |
| ndc | 13107-073-25 |
| ndc | 13107-073-05 |
| ndc | 13107-073-99 |
| ndc | 13107-074-50 |
| ndc | 13107-074-01 |
| ndc | 13107-074-25 |
| ndc | 13107-074-05 |
| ndc | 13107-074-99 |
| code_info | Batch 07319032A1, Exp 02/2021 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0143-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.